Ectonucleotide Pyrophosphatase Phosphodiesterase Deficiency
📧 Sign up to get email alerts when something new happens for Ectonucleotide Pyrophosphatase Phosphodiesterase Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-01Clinical Trial Update: The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 Deficiency [Phase 2]
The Phase 2 ENABLE study evaluating INZ-701 for ENPP1 deficiency and related diseases has been withdrawn.
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency [Phase 2]
This Phase 2 long-term safety study of INZ-701 in patients with ENPP1 deficiency and ABCC6-related disease is currently recruiting.